+ Resolve Article
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter

+ Translate
+ Subscribe to Site Feed
GeoScience Most Shared ContentMost Shared Content

Compliance with safe practices for preparing parenteral nutrition formulations

, : Compliance with safe practices for preparing parenteral nutrition formulations. American Journal of Health-System Pharmacy 59(3): 264-269

Compliance with the guidelines of the National Advisory Group on Standards and Practice Guidelines for Parenteral Nutrition (NAG) was studied. A questionnaire based on the NAG guidelines was developed to identify common practices used in the preparation of parenteral nutrition formulations in a variety of health care settings. The questionnaire was mailed in January 2000 to a national sample of 1445 pharmacists. There were a total of 633 usable responses, for a net response rate of 45.2% (based on 1400 deliverable surveys). Almost 80% of the respondents were employed in an urban setting, and 64.3% worked in hospitals. Relatively high compliance was reported for guidelines related to filtration (86.9% and 85.9%), verification of product stability and compatibility by a pharmacist or computer program (86.4%), evaluation of the aseptic technique of persons preparing sterile products (81.4%), and having a pharmacist assess formulations to determine whether the contents are within acceptable standard ranges (78.8%). Low compliance was reported for guidelines related to the inclusion of dosing weight on the label (15.4%), the use of amount per day as the unit of measure for labeling ingredients (26.1%), direct pharmacist-to-pharmacist communication about prescriptions when patients are transferred among health settings (33.4%), and daily in-process or end-product quality assurance testing of formulations. The NAG guidelines on parenteral nutrition formulations with which pharmacists' practice was most discrepant were the use of amount per day as the unit of measure for labeling ingredients, inclusion of the patient's dosing weight on the label, direct pharmacist-to-pharmacist communication when patients are transferred, and daily quality assurance testing.


PMID: 11862638

Other references

Birx, D.L.; Van Cott, T.; Sitz, K.; Ratto, S.; Loomis, L.; Michael, N.; Robb, M.; Burnett, P.; Kim, J.; Redfield, R., 1994: HIV vaccine development Insights from vaccine therapy studies. AIDS Research & Human Retroviruses 10(SUPPL 3): S154

L.V.n Quyen, M.; Staba, R.; Bragin, A.; Dickson, C.; Valderrama, M.; Fried, I.; Engel, J., 2010: Large-scale microelectrode recordings of high-frequency gamma oscillations in human cortex during sleep. Gamma oscillations (40-120 Hz), usually associated with waking functions, can be recorded in the deepest stages of sleep in animals. The full details of their large-scale coordination across multiple cortical networks are still unknown. Furthermor...

Borman, S.; Stouffer, R.; Molskness, T.; Battaglia, D.; Patton, P., 2003: Insulin and Insulin-Like Growth Factors promote Vascular Endothelial Growth Factor secretion by human luteinizing granulosa cells following Controlled Ovarian Stimulation. Fertility & Sterility 80(Suppl 3): S278, September

Bonnin, S.; Besson, F.; Gelhausen, M.; Chierici, S.; Roux, B., 1999: A FTIR spectroscopy evidence of the interactions between wheat germ agglutinin and N-acetylglucosamine residues. Wheat germ agglutinin (WGA), a lectin binding a N-acetyl-D-neuraminic acid (NeuNAc) and/or N-acetyl-D-glucosamine (GlcNAc) group, was studied by Fourier transform infrared (FTIR) spectroscopy. Deconvolution of the FTIR spectrum of WGA alone indica...

Sergi, C.; Kahl, P.; Otto, H.F., 2001: Immunohistochemical localization of transforming growth factor-alpha and epithelial growth factor receptor in human fetal developing skin, psoriasis and restrictive dermopathy. Keratinocytes release a number of cytokines interacting with other intra- and subepidermal cells during the initiation and the perpetuation of skin inflammatory reactions. Cultured human keratinocytes overexpressing the transforming growth factor...

Ebe T., 1979: Electron microscopic observation of pulmonary alveolar proteinosis on the origin of proteinaceous material in the alveoli. Japanese Journal Of Clinical Electron Microscopy6: 912

Casiglia, E.; Biasin, R.; Cavatton, G.; Capuani, M.; Marotti, A.; Onesto, C.; Tramontin, P.; Pessina, A.C., 1996: Lower blood pressure values in blood donors?. 594 blood donors were studied to define the influence of regular blood donation on blood pressure. Blood pressures were compared at the first phlebotomy performed at the Padova Blood Unit, the 13-year phlebotomy, and the median between the two. As...

Ory, M.G.; Mier, N.; Sharkey, J.R.; Anderson, L.A., 2007: Translating science into public health practice: lessons from physical activity interventions. Alzheimer's & Dementia 3(2 Suppl): S52-S57

Soria, D.; Garibaldi, J.M.; Ambrogi, F.; Green, A.R.; Powe, D.; Rakha, E.; Macmillan, R.Douglas.; Blamey, R.W.; Ball, G.; Lisboa, P.J.G.; Etchells, T.A.; Boracchi, P.; Biganzoli, E.; Ellis, I.O., 2010: A methodology to identify consensus classes from clustering algorithms applied to immunohistochemical data from breast cancer patients. Single clustering methods have often been used to elucidate clusters in high dimensional medical data, even though reliance on a single algorithm is known to be problematic. In this paper, we present a methodology to determine a set of 'core...

Anders, K.T., 1993: Long-term concerns. The industry reacts to Clinton's plan to reform the health-care system. Contemporary Longterm Care 16(11): 42-44